interesting-US Fed News Service, Including US State News
Apr 7, 2015
US Patent Issued to Compugen on April 7 for "Compositions and methods for treatment of drug resistant multiple myeloma" (American, Israeli Inventors)
ALEXANDRIA, Va., April 7 -- United States Patent no. 8,999,335, issued on April 7, was assigned to Compugen Ltd. (Tel Aviv, Israel).
"Compositions and methods for treatment of drug resistant multiple myeloma" was invented by Gad S. Cojocaru (Ramat HaSharon, Israel), Haiming Chen (West Hillls, Calif.) and James Berenson (Beverly Hills, Calif.).
According to the abstract* released by the U.
S. Patent & Trademark Office: "This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against TMEM154 antigens, which are differentially expressed in cancer, and diagnostic and therapeutic usages, wherein the cancer is relates to multiple myeloma, including multiple myeloma precursor diseases. This invention further relates to extracellular domains of TMEM154 proteins and variants, and therapeutic usages thereof."
The patent was filed on Sept. 16, 2011, under Application No. 13/821,176.
*For further information, including images, charts and tables, please visit:
glad to see 2014 behind CVV - 6.7 mm dollars spent on Taiwan Glass..!! thats around $1.10 PER SHARE of earnings.. the way i see it.. if there is 10-20% growth this year , and we are at All time high bookings revenues etc.. will be 16 to 18 mm in gross profit before SGA - thats $2.50 to $3.0 bucks a share gross profit- THEN lets say 7 mm in SGA for 2015 ( recall 1.8 mm was for legal fees on 2014!! AND the 4.95 settlelment .. 6.7mm GONE) - SO - say CVV makes 9-10 mm in net income for 2015 thats 1.50 per share at say a 14 multiple ( S&P at 17 for 2019 numbers not 2015! ) you get to 21 bucks per share .. simple math NOT even looking beyond 2015 ... this will go HIGHER